21647 ⎘
Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups -
NUTRITIONAL APPROACH TO THE CONTROL OF ANEMIA, DIABETES AND OTHER DISEASES OR CONDITIONS AND PREVENTION OF ASSOCIATED COMORBID STATES WITH THE USE OF ERGOTHIONEINE
#3002Compositions and methods for treatment of intracellular damage and bacterial infection
#3003BIFIDOBACTERIA FOR TREATING DIABETES AND RELATED CONDITIONS
#3004Avian follistatin product
#3005TREATMENT METHODS FOR DEHYDRATION USING LIPOSOMAL REHYDRATION SALT FORMULATION
#3006COMPOSITION AND METHOD FOR PROMOTING REDUCTION OF HEAT STRESS IN ANIMALS
#3007ENHANCED CANCER TREATMENT AND MONITORING USING RECOMBINANT VECTORS
#3008COMBINATION COMPRISING AN OMEGA-3 FATTY ACID COMPOSITION AND AN SGLT2 INHIBITOR
#3009Method of safely and effectively treating and preventing secondary hyperparathyroidism in chronic kidney disease
#3010Adjunctive Therapy With 25-Hydroxyvitamin D and Articles Therefor
#3011Nutritional intervention for improving muscular function and strength
#3012EMULSION FORMULATIONS
#3013Autotaxin inhibitors
#3014Methods for treating subjects with prader-willi syndrome or smith-magenis syndrome
#3015Methods and compositions for the treatment or prevention of abnormal bone formation in a soft tissue
#3016Salt of a pyrimido[6,1-A]isoquinolin-4-one compound
#3017TREATMENT OF CORNEAL NEOVASCULARIZATION
#3018Benzoisoxazole-substituted compounds as MGLUR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
#3019SIGMA LIGANDS FOR POTENTIATING THE ANALGESIC EFFECT OF OPIOIDS AND OPIATES IN POST-OPERATIVE PAIN AND ATTENUATING THE DEPENDENCY THEREOF
#3020Combination Treatment
#3021PTGDR-1 AND/OR PTGDR-2 ANTAGONISTS FOR PREVENTING AND/OR TREATING SYSTEMIC LUPUS ERYTHEMATOSUS
#3022Neuroprotection in Demyelinating Diseases
#3023Formulations for oral administration of active agents
#3024Compositions containing alpha-2-adrenergic agonist components
#3025COMPOSITIONS AND METHODS FOR IMPROVED SKIN CARE
#3026Inhibitors of the renal outer medullary potassium channel
#3027Substituted pyrazole compounds as RORgammaT inhibitors and uses thereof
#3028USE OF ISOTHIOCYANATE FUNCTIONAL SURFACTANTS AS NRF2 INDUCERS TO TREAT EPIDERMOLYSIS BULLOSA SIMPLEX AND RELATED DISEASES
#3029Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome
#3030METHODS FOR ON DEMAND PRE-EXPOSURE PROPHYLACTIC TREATMENT OF HIV INFECTION
#3031Combination therapies
#3032Healing topical composition
#3033ERR ALPHA AND ERR GAMMA ARE ESSENTIAL COORDINATORS OF CARDIAC METABOLISM AND FUNCTION
#3034Design, synthesis and methods of use of acyclic fleximer nucleoside analogues having anti-coronavirus activity
#3035SYSTEM AND METHOD OF COMPLEMENTARY DAY/NIGHT CHILDREN'S SKIN CREAM COMPOSITIONS
#3036Salts of aza-bicyclic di-aryl ethers and methods to make them or their precursors
#3037Combination of hyaluronic acid and macrogol and pharmaceutical compositions containing it
#3038Nutritional compositions comprising human milk oligosaccharides and nucleotides and uses thereof for treating and/or preventing enteric viral infection
#3039Pteridine dione monocarboxylate transporter inhibitors
#3040Gel local anesthetic agent and gel local anesthetic preparation using same
#3041PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CHRONIC MYELOID LEUKEMIA AND METHOD USING THE SAME
#3042Composition and method for treating congenital cytomegalovirus induced hearing loss
#3043Process for preparing an anti-cancer agent, 1-((4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-6-methoxyquinolin-7-yloxy)methyl)cyclopropanamine, its crystalline form and its salts
#3044Diindole compounds useful in treatment of nervous system disorders
#3045Methods and pharmaceutical compositions for the treatment of ischemic conditions
#3046Complexes of celecoxib and its salts and derivatives, process for the preparation thereof and pharmaceutical compositions containing them
#3047Combined treatment with a TLR7 agonist and an HBV capsid assembly inhibitor
#3048STABLE PHARMACEUTICAL COMPOSITIONS COMPRISING ANTIBACTERIAL AGENT
#3049(S)-N-(3-(6-isopropoxypyridin-3-yl)-1H-indazol-5-yl)-1-(2-(4-(4-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)-3,6-dihydropyridin-1(2H)-yl)-2-oxoethyl)-3-(methylthio)pyrrolidine-3-carboxamide compositions for pharmaceutical preparations
#3050TREATMENT FOR NON-ALCOHOLIC FATTY LIVER DISEASES
#3051Herbal Tea Compositions for Babies
#3052Kv1.3 inhibitors and their medical applications
#3053Pharmaceutical Semi-Solid Gels with Entrapped Calcium Phosphate Nanoparticles
#3054NON-TOXIC TOPICAL ANESTHETIC OPHTHALMIC COMPOSITIONS
#3055Reduction of milk glycans and their degradation products in the neonate gut
#3056COMPOSITION
#3057Solid antiviral dosage forms
#3058TREATMENT OF LUPUS NEPHRITIS USING LAQUINIMOD
#3059CRYSTAL FORMS OF APOMORPHINE AND USES THEREOF
#30605,5-bicyclic oxazole orexin receptor antagonists
#3061Imidazole-based antimicrobial agents
#3062SOLID DISPERSION FORMULATIONS OF ANTIVIRAL COMPOUNDS
#3063AQUEOUS COMPOSITION
#3064Bars and Shakes utilizing proprietary blend of herbs for enhanced human lactation and breastfeeding.
#3065Treatment of angiogenesis disorders
#3066Compositions and Methods for Inducing Nanoparticle Mediated Microvascular Embolization of Tumors
#3067Immunogenic formulations comprising linear or branched polyacrylic acid polymer adjuvants
#3068Method for reducing flu-like symptoms associated with intramuscular administration of interferon using a fast titration escalating dosing regimen
#3069Hypochlorous acid formulations and methods for treating skin conditions
#3070Subcutaneously administered anti-IL-6 receptor antibody for treatment of juvenile idiopathic arthritis
#3071C-19 steroids for inhibiting neovascularization
#3072Organic compounds
#30733-(PIPERIDIN-4-YL)-ISOXAZOL-3(OH)-ONES FOR TREATMENT OF DERMATOLOGIC DISORDERS
#3074Inhibitors of bromodomains
#3075Substituted heterocycles as bromodomain inhibitors
#3076Organic compounds
#3077Polymorph of granaticin B
#3078USE OF RASAGILINE FOR THE TREATMENT OF RESTLESS LEGS SYNDROME
#3079Process for increasing the stability of a composition comprising polyunsaturated omega-3 fatty acids
#3080Compositions and methods for detection of hepatitis C virus genotype 3
#3081Quinazoline heterocyclic compound as EGFR kinase inhibitor and preparation and application thereof
#3082Method for treating gout and gout-induced arthritis using composition containing mixed extract of and
#3083Prodrugs of 17.BETA.-HSD1-inhibitors
#3084Methods and compositions for the treatment of pre-diabetes, diabetes and metabolic syndrome
#3085Compositions and methods for treating and preventing infections
#3086Medicinal composition of extract of seed of emblica officinalis and method of preparing the same
#3087Combination Drug Therapy
#3088Treatment of solid tumours
#3089ENHANCEMENT OF IMPAIRED MOTOR AND MENTAL FUNCTIONS, USING DEXTROMETHORPHAN AND OXIDASE ENZYME INHIBITOR
#3090Enhancement of antibiotic efficacy
#3091Ophthalmic drug delivery
#30921,3,5 -triazine based PI3K inhibitors as anticancer agents and a process for the preparation thereof
#3093Nucleic acid complexes
#3094CYCLIC PEPTIDE SPECIFICALLY BINDING TO APOPTOTIC CELLS AND USE THEREOF
#3095Prevention of progressive heart failure
#3096MINERAL COMPLEX FORMULATIONS FOR ORAL ADMINISTRATION AND METHODS FOR THEIR USE
#3097COMBINED USE OF A CHEMOTHERAPEUTIC AGENT AND A CYCLIC DINUCLEOTIDE FOR CANCER TREATMENT
#3098BTK inhibitors
#3099Treatment of pediatric BCP-ALL patients with an anti-KIR antibody
#3100Imidazole-based antimicrobial agents
#3101Process for the preparation of raltegravir
#3102COMPOSITIONS AND METHODS FOR ENHANCING THE METABOLIC ACTIVITY OR STABILITY OF CURCUMIN
#3103Probiotic pathogen inhibition composition and method
#3104SUBSTITUTED IMIDAZO[1,5-A]PYRIMIDINES AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS
#3105Methods and devices for the treatment of ocular diseases in human subjects
#3106Apilimod for use in the treatment of renal cancer
#3107Pharmaceutical composition for preventing or treating immune diseases or inflammatory diseases, containing biguanide derivative compound as active ingredient
#3108Methods of treating skin cancer by administering a PD-1 inhibitor
#3109Methods and systems for treating or preventing cancer
#3110Method for treatment of metastatic and refractory cancers and tumors with an inducer that overcomes inhibition of T cell proliferation
#3111Mouth freshener
#3112Prevention or treatment of uratic or gouty diseases
#3113Drug treatment of tumors wherein hedgehog/smoothened signaling is utilized for inhibition of apoptosis of tumor cells
#3114Device for delivery of a pharmaceutical composition
#3115Crystalline polymorphic forms of monosodium N-[-8-(2-hydroxybenzoyl)amino]caprylate
#3116COMPOSITION OF SOLUBLE INDIGESTABLE FIBERS AND OF EUKARYOTIC ORGANISMS WITH A POLYSACCHARIDE WALL, USED, IN THE WELL-BEING FIELD
#3117Anti-CD38 antibodies for treatment of acute lymphoblastic leukemia
#3118Therapeutic agent for autoimmune diseases comprising PD-1 agonist
#3119Pentadienoyl piperidine derivative and use thereof
#3120Synergistic compositions
#3121SULFAMOYLBENZAMIDE DERIVATIVES AS ANTIVIRAL AGENTS AGAINST HBV INFECTION
#3122Catheter locking solution having antimicrobial and anticoagulation properties
#3123Combination of drugs with protein-binding prodrugs
#3124DIHYDROXYPHENYL NEUROTRANSMITTER COMPOUNDS, COMPOSITIONS AND METHODS
#3125Combination therapy for treating breast cancer
#3126Methods, regimens, combinations and antagonists
#3127AGENT FOR USE IN THE CASE OF FRUCTOSE INTOLERANCE
#3128COMPOSITION FOR THE TREATMENT OF DISEASE
#3129METHODS AND COMPOSITIONS COMPRISING AKT INHIBITORS AND/OR PHOSPHOLIPASE D INHIBITORS
#3130Methods and Compositions for Treating Thyroid-Related Medical Conditions with Reduced Folates
#3131Compounds and their use as BACE inhibitors
#3132COMBINATION DRUG TREATMENT FOR HEPATITIS C INFECTION
#3133COMBINATION OF LAQUINIMOD AND PRIDOPIDINE FOR TREATING NEURODEGENERATIVE DISORDERS, IN PARTICULAR HUNTINGTON'S DISEASE
#3134CAI-BASED SYSTEMS AND METHODS FOR THE LOCALIZED TREATMENT OF UVEITIS
#3135Anesthetic comprising tetracaine and a vasoconstrictor for administration to a subject
#3136Compositions and methods of use of phorbol esters
#3137Curcuphenol compounds for increasing MHC-I expression
#3138ENHANCED STABILITY OF NOVEL LIQUID COMPOSITIONS
#3139Lice control composition and method
#3140Beta-lactamases with improved properties for therapy
#3141Analogs of adenosine monophosphate (AMP) as inhibitors of ubiquitin-like modifier-activating enzyme ATG7
#3142METHOD OF CONTRACEPTION
#3143GENE DRO1 CONTROLLING DEEP-ROOTED CHARACTERISTICS OF PLANT AND UTILIZATION OF SAME
#3144METHODS AND MATERIALS FOR IDENTIFYING COMPOUNDS PROMOTING TRANSLATIONAL READ-THROUGH OF NONSENSE MUTATIONS
#3145Indication of antibiotic drugs for preparation of cancer inhibition pharmaceutical composition
#3146Small molecule Ras inhibitors
#3147HALOGENATED INSULIN ANALOGUES OF ENHANCED BIOLOGICAL POTENCY
#3148PRIMARY AND SECONDARY PREVENTION OF DEMENTIAS AND SUICIDE WITH TRACE DOSE LITHIUM
#3149PHARMACEUTICAL COMPOSITION FOR TREATING A VIRAL INFECTION
#3150Ophthalmic solution
#3151Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects
#3152Tetrahydropyrazolopyridine derivatives as ghrelin receptor agonists
#3153Dyslipidemia therapeutic agent
#3154NEW INDICATION OF CINACALCET HCL PHARMACEUTICAL COMPOSITION FOR TREATING CANCER
#3155Use of cannabinoids in the treatment of degenerative skeletal muscle diseases
#3156Estrogen receptor ligand treatment for neurodegenerative diseases
#3157Compositions and methods for increasing the bioavailability of one or more compounds
#3158Combination of valerian root extract and lavender oil for use in the treatment of sleep disorders
#3159Administration of butyrate, beta-hydroxybutyrate, and related compounds in humans
#3160Solid Forms of Mirabegron
#3161Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease
#3162Antiviral agents and uses thereof
#3163PCSK9 Inhibitors and Methods of Use Thereof
#3164Aminoalkylbenzothiazepine derivatives and uses thereof
#3165Pharmaceutical compositions and their use for treatment of cancer and autoimmune diseases
#3166METHOD OF TREATING PATIENTS NON-RESPONSIVE TO PALONOSETRON
#3167METHODS OF USING ADIPOSE TISSUE-DERIVED CELLS IN THE TREATMENT OF CARDIOVASCULAR CONDITIONS
#3168PROBIOTICS, SECRETORY IgA AND INFECTION
#3169Combination of an insulin and a GLP-1 agonist
#3170UNITARY COMBINATION OF FSH AND HCG
#3171Treatment of Constipation-Predominant Irritable Bowel Syndrome
#3172A METHOD FOR SIDE EFFECT REDUCTION IN THE USE OF STATINS VIA PHYSIOLOGICALLY SYNTHESIZED GLUTATHIONE
#3173Method of identifying a biologically-active composition from a biofilm
#3174Scaffold Delivery of Immune Suppressors and Transplant Material for Control of Transplant Rejection
#3175USE OF NITRITE SALTS FOR THE TREATMENT OF CARDIOVASCULAR CONDITIONS
#3176Systems and methods for delivery of peptides
#3177NON-ANTICOAGULANT SULFATED OR SULFONATED SYNTHETIC POLYMERS
#3178Use of sedoheptulose for prevention or treatment of inflammation
#3179Use of thiopyrimidinecarboxamide for treating cancer
#3180Methods of treating retroviral infections and related dosage regimes
#3181Therapeutic Compositions and Methods
#3182Salt of cephalosporin derivative, its crystalline solid and a method of manufacturing thereof
#3183ANTIVIRAL THERAPY
#3184CHEMICALLY AND METABOLICALLY STABLE DIPEPTIDE POSSESSING POTENT SODIUM CHANNEL BLOCKER ACTIVITY
#3185Combination therapy of a type II anti-CD20 antibody with a selective BCL-2 inhibitor
#3186Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects
#3187Combination therapy
#3188Use of 4-Aminopyridine to Improve Neuro-Cognitive and/or Neuro-Psychiatric Impairment in Patients with Demyelinating and Other Nervous System Conditions
#3189Methods of treating hepatic encephalopathy
#3190Compositions and methods for treating plasma cell disorders and B-cell prolymphocytic disorders
#3191Treatment of cancer with specific RXR agonists
#3192Treatment of cancer with specific RXR agonists
#3193METHODS FOR THE TREATMENT OF ROSACEA
#3194THERAPEUTIC ASTAXANTHIN AND PHOSPHOLIPID COMPOSITION AND ASSOCIATED METHOD
#3195Method of reducing scarring
#3196Taurine compositions suitable for inhalation
#3197Compositions and methods useful for the prevention of malaria and dengue virus transmission
#3198Methods and compositions related to prostate cancer therapeutics
#3199Compositions and methods for treating or preventing lupus
#3200Methods of preserving and protecting pancreatic beta cells and treating or preventing diabetes by inhibiting NOX-1
#3201Method of making an artificial micro-gland using taxis
#3202Combination therapy with T-cell redirecting bispecific antibodies and checkpoint inhibitors
#3203Bispecific EGFR/C-Met Antibodies
#3204PTERIDINES USEFUL AS HCV INHIBITORS AND METHODS FOR THE PREPARATION THEREOF
#3205Estrogen receptor modulators and uses thereof
#3206Methods, compositions and kits for providing a therapeutic treatment
#3207COMBINING ANTI-HLA-DR OR ANTI-TROP-2 ANTIBODIES WITH MICROTUBULE INHIBITORS, PARP INHIBITORS, BRUTON KINASE INHIBITORS OR PHOSPHOINOSITIDE 3-KINASE INHIBITORS SIGNIFICANTLY IMPROVES THERAPEUTIC OUTCOME IN CANCER
#3208Method for reducing damage caused by free radicals
#3209METHOD AND APPARATUS FOR HARVESTING, CREATING AND IMPLANTING A FIBRIN CLOT BIOMATERIAL
#3210Pharmaceutical compositions and methods
#3211Methods and materials for increasing lean muscle mass
#3212PHARMACEUTICAL COMPOSITIONS FOR TREATING ANXIETY
#3213Buccal and sublingual cannabinoid formulations and method of making the same
#3214Method for preparing a biological tissue construct and use of autologous cells obtained specifically
#3215PLATELET RICH PLASMA FORMULATIONS AND USE THEREOF
#3216Immune modulation using peptides and other compositions
#3217MULTIPLE FOLATE FORMULATION AND USE THEREOF
#3218Pharmaceutical compositions for preventing glucocorticoid-induced corneal thinning
#3219Treatment of congestion using steroids and adrenergics
#3220Pharmaceutical formulations and uses thereof in the treatment of female sexual dysfunction
#3221Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators
#3222METHODS AND COMPOSITIONS FOR BACTERIA INFECTIONS
#3223Methods of treating liver disease
#3224Pharmaceutical composition for topical administration
#3225Taxane Analogs for the Treatment of Brain Cancer
#3226Treatment of Triple Receptor Negative Breast Cancer
#3227Anti-tumor compound and the medical use thereof
#3228Methods to treat neurodegenerative diseases
#3229Composition for preventing the occurrence of cardiovascular event in multiple risk patient
#3230Therapeutic approaches for treating Parkinson's disease
#3231Specific mTOR inhibitors in the treatment of X-linked adrenoleukodystrophy
#3232Controlled extended release pregabalin
#3233Methods and pharmaceutical compositions for treatment of cystic fibrosis
#3234MODULATION OF APOLIPOPROTEIN CIII (APOCIII) EXPRESSION
#3235Fibrinogen preparations enriched in fibrinogen with an extended alpha chain
#3236HERBAL COMPOSITIONS FOR THE PREVENTION OR TREATMENT OF BENIGN PROSTATIC HYPERPLASIA AND RELATED DISORDERS
#3237Hydrogenation of cannabis oil
#3238Compositions for the Restoration of a Fecal Microbiota and Methods for Making and Using Them
#3239Processing methods of solgel-derived bioactive glass-ceramic compositions and methods of using the same
#3240Acetic acid and hypochlorous acid compositions for treatment of biofilms and wound care
#3241Anti-inflammatory solution
#3242Prevention or treatment agent for hepatic fibrosis
#3243COMPOSITION, FORMULATIONS AND METHODS OF MAKING AND USING BOTANICALS AND NATURAL COMPOUNDS FOR THE PROMOTION OF HEALTHY BRAIN AGING
#3244Drug combination of PDE3/PDE4 inhibitor and muscarinic receptor antagonist
#3245USE OF INHIBITORS OF BRUTON'S TYROSINE KINASE (BTK)
#3246PHARMACEUTICAL COMPOSITIONS FOR COMBINATION THERAPY
#3247USE OF SUBSTITUTED HEXITOLS INCLUDING DIANHYDROGALACTITOL AND ANALOGS TO TREAT NEOPLASTIC DISEASE AND CANCER STEM CELLS INCLUDING GLIOBLASTOMA MULTFORME AND MEDULLOBLASTOMA
#3248Compositions and methods for producing elevated and sustained ketosis
#3249INJECTABLE RESINIFERATOXIN
#3250Foods, systems, methods, and kits for providing electrolyte replacement
#3251Use of cannabinoids in the treatment of epilepsy
#3252Colon cleansing compositions and methods of use
#3253Stable pharmaceutical formulations of methylnaltrexone
#3254USE OF OPIOID ANTAGONISTS TO ATTENUATE ENDOTHELIAL CELL PROLIFERATION AND MIGRATION
#3255Immunostimulating Polyphosphazene Compounds
#3256Protease-engineered Cancer Cell Spheres as an Immunotherapy to Treat Cancer and non-Cancer Diseases
#3257Treatment of Herpes, Pseudomonas, Staph, and Hepatitis
#3258and subsp. for use in prevention or treatment of upper respiratory tract infections
#3259Cell preparations for extemporaneous use, useful for healing and rejuvenation in vivo
#3260AMINE POLYMERS FOR USE AS BILE ACID SEQUESTRANTS
#3261Methods and compositions to reduce oxidative stress
#3262CARBOSTYRIL DERIVATIVES AND SEROTONIN REUPTAKE INHIBITORS FOR TREATMENT OF MOOD DISORDERS
#3263TREATMENT OF LUPUS NEPHRITIS USING LAQUINIMOD
#3264ANTI-CANCER AGENT DELIVERY VEHICLES CAPABLE OF IMPROVED LOADING
#3265Self-micellizing fatty acids and fatty acid ester compositions and their use in the treatment of disease states
#3266ACETIC ACID/THYMOL COMPOSITIONS AND THEIR USE IN THE TREATMENT OF ONYCHOMYCOSIS
#3267Mixed salt compositions for maintaining or restoring electrolyte balance while producing elevated and sustained ketosis
#3268Treatment of prostate carcinoma
#3269Treatment and prevention of cardiovascular disease and thrombosis
#3270Topical skin care formulations comprising botanical extracts
#3271Methods for reversing multiple resistance in animal cells
#3272Peptides and compositions for treatment of joint damage
#3273METHODS AND COMPOSITIONS FOR TREATING RETINAL DISORDERS
#3274Brain and neural treatments comprising peptides and other compositions
#3275MESENCHYMAL STROMAL CELLS AND USES RELATED THERETO
#3276Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome
#3277USE OF OPIOID ANTAGONISTS TO ATTENUATE ENDOTHELIAL CELL PROLIFERATION AND MIGRATION
#3278Methods of Modulating Gastrointestinal Tract Flora Levels with Alkaline Phosphatase
#3279MAZINDOL COMBINATION IN THE TREATMENT OF ATTENTION DEFICIT/HYPERACTIVITY
#3280Wound healing
#3281Method of treating neuropathic pain with a synergistic pharmaceutical composition comprising palmitoylethanolamide and L-acetylcarnitine
#3282Omega-3 compositions, dosage forms, and methods of use
#3283REDUCING MYOCARDIAL DAMAGE AND THE INCIDENCE OF ARRHYTHMIA ARISING FROM LOSS, REDUCTION OR INTERRUPTION IN CORONARY BLOOD FLOW
#3284Methods for treating red blood cells
#3285Benzylideneguanidine derivatives and therapeutic use for the treatment of protein misfolding diseases
#3286Hemostatic compositions and dressings for bleeding
#3287Compositions and methods for treatment of pre-cancerous skin lesions
#3288MULTILAMELLAR LIPID VESICLE COMPOSITIONS AND METHODS OF USE
#3289Altering microbial populations and modifying microbiota
#3290PHACOSCLEROSIS INHIBITOR
#3291Inhibitors of Bruton's Tyrosine Kinase for the Treatment of Solid Tumors
#3292COMBINATION OF LBH589 WITH OTHER THERAPEUTIC AGENTS FOR TREATING CANCER
#3293POLYPHENOL FOR WOUND HEALING
#3294Use of Artemisinin for Treating Tumors Induced by Oncogenic Viruses and for Treating Viral Infections
#3295Compositions and methods for preventing and recovery from detrimental effects of alcohol consumption
#3296Famciclovir and celecoxib combination therapy for functional somatic syndromes
#3297Method of treating or preventing tumors of the central nervous system
#3298Acellular biologic composition and method of manufacture
#3299Omega-3 fatty acid ester compositions
#3300Biologic composition and method of manufacture